MMTZFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as RLFTY

MindMaze Therapeutics Holding SA

Financials through fiscal 2023, year ended Dec 31, 2023Last filing: 20-F on Apr 30, 2024

$0.19−0.00 (-0.22%)

Close on Oct 19, 2026

Community

Notes and questions about MindMaze Therapeutics from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in MindMaze Therapeutics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-400 reverse split on Apr 30, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MMTZF.

Revenue growth-11.0% · median 11.8%

Operating margin-1751.4% · median -21.9%

Advertisement
300 × 250